Effect of meloxicam on gingival crevicular fluid IL-1beta and IL1 receptor antagonist levels in subjects with chronic periodontitis, and its effects on clinical parameters

Clinical Oral Investigations

Volumn 10, Issue 4, 2006, Pages 305-310

  Toker, Hulya ^a   Marakoglu, Ismail ^b   Poyraz, Omer ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Chronic periodontitis; IL 1 ; IL 1ra; Meloxicam

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MELOXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; CHEMISTRY; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; GINGIVITIS; HUMAN; MALE; MIDDLE AGED; PERIODONTITIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHRONIC DISEASE; CYCLOOXYGENASE INHIBITORS; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PERIODONTITIS; THIAZINES; THIAZOLES;

EID: 33751517047     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-006-0062-3     Document Type: Article

References (25)

1. 2 and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 67:755-762
2. Bezerra MM, de Lima V, Alencar VBM et al (2000) Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 71:1009-1014
3. Boström L, Linder LE, Bergstrom J (2000) Smoking and GCF levels of IL-1β and IL-1ra in periodontal disease. J Clin Periodontol 27:250-255
4. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. New Engl J Med 14:106-113
5. Figueredo CMS, Riberio MSM, Fischer RG, Gustafsson A (1999) Increased interleukin-1β concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 70:1457-1463
6. Gamanol J, Acevedo A, Bascones A, Jorge O, Silva A (2000) Levels of Interleukin-1β, -8, -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71:1535-1545
7. Giannopoulou C, Cappuyns I, Mombelli A (2003) Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis. J Clin Periodontol 30:996-1002
8. Giannopoulou C, Kama JJ, Mombelli A (2003) Effect of inflammation, smoking, and stress on gingival, crevicular fluid cytokine level. J Clin Periodontol 30:145-153
9. Gonzales JR, Herrmann JM, Boedeker RH, Francz PI, Biesalski H, Meyle J (2001) Concentration of interleukin-1β and neutrophil elastase activity in gingival crevicular fluid during experimental gingivitis. J Clin Periodontol 28:544-549
10. Heath JK, Saklatvala J, Meikle MC, Atkinson SJ, Reynolds JJ (1985) Pig interleukin-1 (catabolin) is a potent stimulator of bone resorption. Calcif Tissue Int 37:95-97
11. Howell TH (1993) Blocking peridontal disease progression with anti-inflammatory agents. J Periodontol 64:828-833
12. Howell TH, Jeffcoat MK, Goldhaber P, Reddy MS, Kaplan ML, Johnson HG (1991) Inhibition of alveolar bone loss in beagles with the NSAID naproxen. J Periodontal Res 26:498-501
13. Ishihara Y, Kuroyagani T, Shirozi N et al (1997) Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 32:524-529
14. Jeffcoat MK, Reddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP (1995) A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 66:329-338
15. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P (1988) Flurbiprofen treatment of human periodontitis: Effect on alveolar bone height and metabolism. J Periodontal Res 23:381-385
16. Kabashima H, Nagata K, Hasguchi I, Toriya Y, Iijima T, Maki K, Maeda K (1996) Interleukin-1 receptor antagonist and interleukin-4 in gingival crevicular fluid of patients with inflammatory periodontal disease. J Oral Pathol Med 25:449-455
17. Löe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38:610-616
18. Penglis PS, James MJ, Cleland LG (2001) Cyclooxygenase inhibitors: Any reservations? Review. Intern Med J 31:37-41
19. Rainsford KD (1994) Non-steroidal anti-inflammatory drugs. In: Dale MM, Foreman JC, Fan T-PD (eds) Textbook of immunopharmacology. Blackwell, Oxford, pp 309-319
20. Rawlinson A, Dalati MHN, Rahman S, Walsh TF, Fairlough AL (2000) Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 27:738-743
21. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK (1993) Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 20:635-640
22. Tatakis DN (1993) Interleukin-1 and bone metabolism: A review. J Periodontol 64:416-431
23. William RC, Offenbacher S, Jefcoat MK, Howell TH, Johnson HG, Hall CM (1988) Indomethacin or flurbiprofen treatment of periodontitis in beagles: Effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss. J Periodontal Res 23:134-138
24. Williams RC, Jeffcoat MK, Wechter WJ, Johnson HG, Kaplan ML, Goldhaber P (1984) Non-steroidal anti-inflammatory drug treatment of periodontitis in beagles. J Periodontal Res 19:633-637
25. Yoshinari N, Kawase H, Mitani A et al (2004) Effects of scaling and root planning on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues. J Periodontal Res 39:158-167